PARIS–(BUSINESS WIRE)–Abbelight, a global leader and a pioneer in super-resolution microscopy end-to-end solutions, today announced a successful Series B financing round led by AVANT BIO, a growth equity firm focused on enabling technologies shaping …
FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
PORTO, Portugal–(BUSINESS WIRE)–FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking…
Allotex Advances from European Commercialization to U.S. Clinical Phase
BOSTON–(BUSINESS WIRE)– #eye–Allotex Inc., a commercial-stage ophthalmic company with active European market adoption, today announced that the U.S. Food and Drug Administration (FDA) has conditionally approved its Investigational Device Exemption (…
Allotex Advances from European Commercialization to U.S. Clinical Phase
BOSTON–(BUSINESS WIRE)– #eye–Allotex Inc., a commercial-stage ophthalmic company with active European market adoption, today announced that the U.S. Food and Drug Administration (FDA) has conditionally approved its Investigational Device Exemption (…
Eye Vessel Blockages: Early Warning for Alzheimer’s Disease?
Patients with retinal vascular occlusion had an elevated risk for Alzheimer’s disease and related dementias, new research shows. Medscape Medical News
Eye Vessel Blockages: Early Warning for Alzheimer’s Disease?
Patients with retinal vascular occlusion had an elevated risk for Alzheimer’s disease and related dementias, new research shows. Medscape Medical News